Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

SARS-CoV-2 target regions

enabled by data from GSAID Logo

EPI_ISL ID Virus name Region Country Collection Date Navigate
EPI_ISL ID: EPI_ISL_19362958 Virus name: hCoV-19/New Zealand/24YA6363/2024 Region: Oceania Country: New Zealand Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362805 Virus name: hCoV-19/USA/NY-PRL-240820_82G10/2024 Region: North America Country: USA Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362786 Virus name: hCoV-19/USA/NY-PRL-240820_82G06/2024 Region: North America Country: USA Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362780 Virus name: hCoV-19/USA/NY-PRL-240820_82A11/2024 Region: North America Country: USA Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362777 Virus name: hCoV-19/USA/NY-PRL-240820_81C08/2024 Region: North America Country: USA Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362767 Virus name: hCoV-19/USA/NY-PRL-240820_82H07/2024 Region: North America Country: USA Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362766 Virus name: hCoV-19/USA/NY-PRL-240820_81F08/2024 Region: North America Country: USA Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362724 Virus name: hCoV-19/USA/NY-PRL-240820_82A09/2024 Region: North America Country: USA Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362707 Virus name: hCoV-19/USA/NY-PRL-240820_81F04/2024 Region: North America Country: USA Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362687 Virus name: hCoV-19/USA/NY-PRL-240820_81F06/2024 Region: North America Country: USA Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362636 Virus name: hCoV-19/Brazil/MT-LACENMT-510563551/2024 Region: South America Country: Brazil Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362635 Virus name: hCoV-19/Brazil/MT-LACENMT-510563473/2024 Region: South America Country: Brazil Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362634 Virus name: hCoV-19/Brazil/MT-LACENMT-510563437/2024 Region: South America Country: Brazil Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362632 Virus name: hCoV-19/Brazil/MT-LACENMT-510563288/2024 Region: South America Country: Brazil Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362631 Virus name: hCoV-19/Brazil/MT-LACENMT-510563093/2024 Region: South America Country: Brazil Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362536 Virus name: hCoV-19/USA/CA-LACPHL-AY07983/2024 Region: North America Country: USA Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362533 Virus name: hCoV-19/USA/CA-LACPHL-AY07984/2024 Region: North America Country: USA Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362532 Virus name: hCoV-19/USA/CA-LACPHL-AY07967/2024 Region: North America Country: USA Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362509 Virus name: hCoV-19/USA/CA-LACPHL-AY07900/2024 Region: North America Country: USA Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362508 Virus name: hCoV-19/USA/CA-LACPHL-AY07899/2024 Region: North America Country: USA Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362297 Virus name: hCoV-19/USA/GA-CDC-LC1115268/2024 Region: North America Country: USA Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362296 Virus name: hCoV-19/USA/KY-CDC-LC1115320/2024 Region: North America Country: USA Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362294 Virus name: hCoV-19/USA/IL-CDC-LC1115316/2024 Region: North America Country: USA Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362291 Virus name: hCoV-19/USA/IL-CDC-LC1115322/2024 Region: North America Country: USA Collection Date: 2024-08-15 Go to details
EPI_ISL ID: EPI_ISL_19362290 Virus name: hCoV-19/USA/VA-CDC-LC1115326/2024 Region: North America Country: USA Collection Date: 2024-08-15 Go to details

Pre-calculated values are obtained by using ThermonucleotideBLAST (Gans JD, Wolinsky M. 2008), which performs in silico simulations with the NAAT methods stored in our database on the selected high-quality (<1% Ns and <0.05% unique amino acid mutations) and full length (>29,000bp) viral genomes made available by GISAID. The aims are both to detect potential target regions of the NAAT methods and to highlight possible differences with the expected reference sequence which might affect the NAAT performance.

The database contains amplicons collected by screening viral shared genomic sequences of SARSCoV- 2 by in silico determination of PCR-based molecular assays to diagnose COVID-19. The information is retrieved periodically. Acknowledgements

GISAID data provided on this website are subject to GISAID's Terms and Conditions